Effects of semaglutide versus comparators on cardiovascular events across a continuum of baseline cardiovascular risk: combined analysis of the SUSTAIN and PIONEER trials

Citation
Husain M, Bain SC, Holst AG, et al. Poster 1161-111 presented at ACC.20/WCC Virtual, 28 March 2020.